cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives

Reuters

2025/10/02

cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives

cbdMD, Inc. (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2572557555"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572557555\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572557555?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 04:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572557555","market":"us","top_or_hot":-1,"title":"cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/YCBD\">cbdMD, Inc.</a> (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\ncbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-10-02 04:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/YCBD\">cbdMD, Inc.</a> (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL7zy1vH:1","article_id":"2572557555","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572557555","pubTimestamp":1759349760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"cbdMD, Inc. , a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes onl","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","YCBD":"cbdMD, Inc."},"translate_title":"cbdMD Inc.在B轮优先私募中筹集170万美元以支持增长计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"YCBD":0.9},"content_text":"cbdMD Inc. Raises $1.7 Million in Series B Preferred Private Placement to Support Growth Initiatives\n    \n\ncbdMD, Inc. (NYSE American: YCBD), a leading wellness company and parent to brands such as Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD, has announced the closing of a $1.7 million Series B Convertible Preferred Stock private placement with institutional investors including C/M Capital Master Fund, LP. The company plans to use the net proceeds of $1.5 million to support working capital, general corporate purposes, and ongoing strategic initiatives. The Series B shares carry a 10% annual dividend and are convertible into common stock at an initial price of $1.00 per share. This financing is intended to strengthen cbdMD's balance sheet, support distribution expansion, and help position the company for sustained profitability and full listing compliance.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 268786) on October 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}